Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00315497 · ClinicalTrials.gov registry record
Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 426
- Enrollment target
NCT00315497: Completed study, sponsored by University of Pennsylvania.
NCT00315497 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 426 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00315497 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 426 participants
- Enrollment target
Study Summary
Giant cell arteritis (GCA), also known as temporal arteritis, is a disease that usually only occurs in older adults. GCA causes inflammation of blood vessels, or vasculitis. In order to properly treat this disease, it is critical that the level of disease activity can be determined over the course of the disease. The purpose of this study is to determine new biological markers, or biomarkers, that may be used to assess the severity of disease in people with GCA.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 426 participants |
| Start Date | 2006-04 |
| Est. Completion | 2019-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00315497
The ClinicalTrials.gov registry entry for NCT00315497 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 426 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00315497 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00315497 about?
NCT00315497 is a clinical study titled "Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis". Giant cell arteritis (GCA), also known as temporal arteritis, is a disease that usually only occurs in older adults. GCA causes inflammation of blood vessels, or vasculitis. In order to properly treat this disease, it is critical that the level of disease activity can be determined over the course o...
What is the current status of trial NCT00315497?
This trial is currently completed. The enrollment target is 426 participants. The study started on 2006-04. Estimated completion is 2019-12.
Who is sponsoring clinical trial NCT00315497?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.